ScienceDaily (Mar. 10, 2011) — Researchers from across multiple disciplines at NYU Langone Medical Center created a new protein molecule derived from the growth factor progranulin may provide the basis for new therapies in inflammatory diseases, such as rheumatoid arthritis, according to a study published in the March 10, 2011 issue of Science.
To read the rest of the article: http://www.sciencedaily.com/releases/2011/03/110310141431.htm